231 related articles for article (PubMed ID: 36849422)
1. HLA-Bw4 in association with KIR3DL1 favors natural killer cell-mediated protection against severe COVID-19.
Wang R; Sun Y; Kuang BH; Yan X; Lei J; Lin YX; Tian J; Li Y; Xie X; Chen T; Zhang H; Zeng YX; Zhao J; Feng L
Emerg Microbes Infect; 2023 Dec; 12(1):2185467. PubMed ID: 36849422
[TBL] [Abstract][Full Text] [Related]
2. HLA-Bw4 80(T) and multiple HLA-Bw4 copies combined with KIR3DL1 associate with spontaneous clearance of HCV infection in people who inject drugs.
Thöns C; Senff T; Hydes TJ; Manser AR; Heinemann FM; Heinold A; Heilmann M; Kim AY; Uhrberg M; Scherbaum N; Lauer GM; Khakoo SI; Timm J
J Hepatol; 2017 Sep; 67(3):462-470. PubMed ID: 28412292
[TBL] [Abstract][Full Text] [Related]
3. Individualized Constellation of Killer Cell Immunoglobulin-Like Receptors and Cognate HLA Class I Ligands that Controls Natural Killer Cell Antiviral Immunity Predisposes COVID-19.
Maruthamuthu S; Rajalingam K; Kaur N; Morvan MG; Soto J; Lee N; Kong D; Hu Z; Reyes K; Ng D; Butte AJ; Chiu C; Rajalingam R
Front Genet; 2022; 13():845474. PubMed ID: 35273641
[No Abstract] [Full Text] [Related]
4. HIV infection abrogates the functional advantage of natural killer cells educated through KIR3DL1/HLA-Bw4 interactions to mediate anti-HIV antibody-dependent cellular cytotoxicity.
Parsons MS; Wren L; Isitman G; Navis M; Stratov I; Bernard NF; Kent SJ
J Virol; 2012 Apr; 86(8):4488-95. PubMed ID: 22345455
[TBL] [Abstract][Full Text] [Related]
5. KIR and HLA genotypes predictive of low-affinity interactions are associated with lower relapse in autologous hematopoietic cell transplantation for acute myeloid leukemia.
Marra J; Greene J; Hwang J; Du J; Damon L; Martin T; Venstrom JM
J Immunol; 2015 May; 194(9):4222-30. PubMed ID: 25810393
[TBL] [Abstract][Full Text] [Related]
6. Donor KIR3DL1/3DS1 gene and recipient Bw4 KIR ligand as prognostic markers for outcome in unrelated hematopoietic stem cell transplantation.
Gagne K; Busson M; Bignon JD; Balère-Appert ML; Loiseau P; Dormoy A; Dubois V; Perrier P; Jollet I; Bois M; Masson D; Moine A; Absi L; Blaise D; Charron D; Raffoux C;
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1366-75. PubMed ID: 19822295
[TBL] [Abstract][Full Text] [Related]
7. Decreased interferon-γ production by NK cells from KIR haplotype B carriers in hepatitis C virus infection.
Mele D; Pasi A; Cacciatore R; Mantovani S; Oliviero B; Mondelli MU; Varchetta S
Liver Int; 2019 Jul; 39(7):1237-1245. PubMed ID: 31177636
[TBL] [Abstract][Full Text] [Related]
8. HLA alleles determine differences in human natural killer cell responsiveness and potency.
Kim S; Sunwoo JB; Yang L; Choi T; Song YJ; French AR; Vlahiotis A; Piccirillo JF; Cella M; Colonna M; Mohanakumar T; Hsu KC; Dupont B; Yokoyama WM
Proc Natl Acad Sci U S A; 2008 Feb; 105(8):3053-8. PubMed ID: 18287063
[TBL] [Abstract][Full Text] [Related]
9. Killer Cell Immunoglobulin-like Receptor Variants Are Associated with Protection from Symptoms Associated with More Severe Course in Parkinson Disease.
Anderson KM; Augusto DG; Dandekar R; Shams H; Zhao C; Yusufali T; Montero-Martín G; Marin WM; Nemat-Gorgani N; Creary LE; Caillier S; Mofrad MRK; Parham P; Fernández-Viña M; Oksenberg JR; Norman PJ; Hollenbach JA
J Immunol; 2020 Sep; 205(5):1323-1330. PubMed ID: 32709660
[TBL] [Abstract][Full Text] [Related]
10. Follicular lymphoma patients with KIR2DL2 and KIR3DL1 and their ligands (HLA-C1 and HLA-Bw4) show improved outcome when receiving rituximab.
Erbe AK; Wang W; Carmichael L; Hoefges A; Grzywacz B; Reville PK; Ranheim EA; Hank JA; Kim K; Seo S; Mendonca EA; Song Y; Kenkre VP; Hong F; Gascoyne RD; Paietta E; Horning SJ; Miller JS; Kahl B; Sondel PM
J Immunother Cancer; 2019 Mar; 7(1):70. PubMed ID: 30871628
[TBL] [Abstract][Full Text] [Related]
11. KIR3DL1 Allelic Polymorphism and HLA-B Epitopes Modulate Response to Anti-GD2 Monoclonal Antibody in Patients With Neuroblastoma.
Forlenza CJ; Boudreau JE; Zheng J; Le Luduec JB; Chamberlain E; Heller G; Cheung NK; Hsu KC
J Clin Oncol; 2016 Jul; 34(21):2443-51. PubMed ID: 27069083
[TBL] [Abstract][Full Text] [Related]
12. The impact of killer cell immunoglobulin-like receptor (KIR) genes and human leukocyte antigen (HLA) class I ligands on predisposition or protection against prostate cancer.
Roshan Zamir M; Ariafar A; Ghaderi A; Amirzargar A
Immunobiology; 2023 Mar; 228(2):152319. PubMed ID: 36599262
[TBL] [Abstract][Full Text] [Related]
13. Mind the gap: lack of association between KIR3DL1*004/HLA‐Bw4-induced natural killer cell function and protection from HIV infection.
Parsons MS; Boulet S; Song R; Bruneau J; Shoukry NH; Routy JP; Tsoukas CM; Bernard NF
J Infect Dis; 2010 Nov; 202 Suppl 3():S356-60. PubMed ID: 20887224
[TBL] [Abstract][Full Text] [Related]
14. Protective genotypes in HIV infection reflect superior function of KIR3DS1+ over KIR3DL1+ CD8+ T cells.
Zipperlen K; Gallant M; Stapleton S; Heath J; Barrett L; Grant M
Immunol Cell Biol; 2015 Jan; 93(1):67-76. PubMed ID: 25112829
[TBL] [Abstract][Full Text] [Related]
15. Association of variably expressed KIR3dl1 alleles with psoriatic disease.
Berinstein J; Pollock R; Pellett F; Thavaneswaran A; Chandran V; Gladman DD
Clin Rheumatol; 2017 Oct; 36(10):2261-2266. PubMed ID: 28801811
[TBL] [Abstract][Full Text] [Related]
16. Association of killer cell immunoglobulin-like receptors and their cognate HLA class I ligands with susceptibility to acute myeloid leukemia in Iranian patients.
Mirzazadeh S; Bemani P; Halimi H; Sanaee MN; Karami N; Ramzi M; Farjadian S
Sci Rep; 2023 Jul; 13(1):11456. PubMed ID: 37454198
[TBL] [Abstract][Full Text] [Related]
17. HLA-B*44 and the Bw4-80T motif are associated with poor outcome of relapse-preventive immunotherapy in acute myeloid leukemia.
Komic H; Hallner A; Hussein BA; Badami C; Wöhr A; Hellstrand K; Bernson E; Thorén FB
Cancer Immunol Immunother; 2023 Nov; 72(11):3559-3566. PubMed ID: 37597015
[TBL] [Abstract][Full Text] [Related]
18. Human immunodeficiency virus type 1 infection is associated with increased NK cell polyfunctionality and higher levels of KIR3DL1+ NK cells in ugandans carrying the HLA-B Bw4 motif.
Eller MA; Koehler RN; Kijak GH; Eller LA; Guwatudde D; Marovich MA; Michael NL; de Souza MS; Wabwire-Mangen F; Robb ML; Currier JR; Sandberg JK
J Virol; 2011 May; 85(10):4802-11. PubMed ID: 21411516
[TBL] [Abstract][Full Text] [Related]
19. KIR3DL1 and HLA-B Density and Binding Calibrate NK Education and Response to HIV.
Boudreau JE; Mulrooney TJ; Le Luduec JB; Barker E; Hsu KC
J Immunol; 2016 Apr; 196(8):3398-410. PubMed ID: 26962229
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory natural killer cell receptor KIR3DL1 with its ligand Bw4 constraints HIV-1 disease among South Indians.
Maruthamuthu S; Rajalingam R; Pandian K; Madasamy S; Manoharan M; Pitchai L; Murugesan A; Mariakuttikan J
AIDS; 2018 Nov; 32(18):2679-2688. PubMed ID: 30289808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
